Low CHD5 expression activates the DNA damage response and predicts poor outcome in patients undergoing adjuvant therapy for resected pancreatic cancer

W. A. Hall, A. V. Petrova, L. E. Colbert, C. W. Hardy, S. B. Fisher, B. Saka, J. W. Shelton, M. D. Warren, B. G. Pantazides, K. Gandhi, J. Kowalski, D. A. Kooby, B. F. El-Rayes, C. A. Staley, N. Volkan Adsay, W. J. Curran, J. C. Landry, S. K. Maithel, D. S. Yu

Research output: Contribution to journal › Article › peer-review